UPMC/UPCI GI Oncology Symposium 2017: Immunotherapy and GI Cancers
Partner with University of Pittsburgh Cancer Institute
Saturday, April 8, 2017
8 a.m. to 5 p.m.
Herberman Conference Center at
UPMC Cancer Pavilion, UPMC Shadyside
The goal of this program is to increase the health care provider’s knowledge of immunotherapies used in GI malignancies.
Who Should Attend
Medical, surgical, and radiation oncologists, gastroenterologists, and other health care providers caring for patients with or at risk for gastrointestinal and colorectal malignancies.
Weijing Sun, MD, FACP
Professor of Medicine
Director of GI Cancers Section of Hematology-Oncology
Co-Director of UPMC GI Cancer Center of Excellence
University of Pittsburgh
Herbert Zeh, III, MD, FACS
Chief, GI Surgical Oncology
Co-Director, UPCI Gastrointestinal Oncology Program
Co-Director, UPMC Pancreatic Cancer Center
Continuing Education Credit
This activity has been approved for AMA PRA Category 1 Credit(s)™
The University of Pittsburgh is an affirmative action, equal opportunity institution.
For more information, contact Mary Kate Egan at firstname.lastname@example.org or 412-623-3651.